文献速递冠心病心律失常

多基因风险评分预测冠心病患者心脏性猝死

Polygenic Risk Score Predicts Sudden Death in Patients With Coronary Disease and Preserved Systolic Function.
PubMed 文献 · J Am Coll Cardiol · 2022-01-01

在PRE-DETERMINE研究的4,698例欧洲血统冠心病且左心室射血分数>30%-35%的患者中,冠状动脉疾病全基因组多基因评分(GPSCAD)最高十分位组与更高的心脏性猝死(SAD)绝对风险和比例风险相关,且独立于左心室射血分数、临床因素和心电图参数。将GPSCAD最高十分位加入多变量模型显著改善净重分类指数,但未显著改善C指数。

要点

  • GPSCAD最高十分位组SAD绝对风险为8.0%,其余组为4.8%。
  • GPSCAD最高十分位与SAD独立相关(subdistribution HR 1.77),与非SAD无关。
  • GPSCAD可能识别可从除颤器治疗中获益的冠心病患者。

核心结论

  • 在无严重收缩功能障碍的冠心病患者中,高GPSCAD特异性预测心脏性猝死,并富集绝对和比例SAD风险。

研究设计与样本

  • 研究纳入PRE-DETERMINE队列中4,698例欧洲血统冠心病且左心室射血分数>30%-35%的参与者,使用已验证的GPSCAD进行基因组分型。
  • 按一般人群定义的GPSCAD最高十分位将人群二分,采用竞争风险分析估计SAD和非SAD的绝对、比例和相对风险。

主要发现

  • 中位随访8.0年,GPSCAD最高十分位组SAD绝对风险为8.0%(95% CI: 5.1%-12.4%),其余组为4.8%(95% CI: 3.3%-7.0%),P=0.005。
  • GPSCAD最高十分位组SAD比例风险为29%,其余组为16%,P=0.0003。
  • 控制左心室射血分数、临床因素和心电图参数后,GPSCAD最高十分位与SAD相关(subdistribution HR: 1.77; 95% CI: 1.23-2.54; P=0.002),与非SAD无关(subdistribution HR: 1.00; 95% CI: 0.80-1.25; P=0.98),P for Δ=0.003。
  • 将GPSCAD最高十分位加入多变量模型显著改善净重分类指数(连续NRI: 14.0%; P=0.024;分类NRI: 6.6%; P=0.005),但未显著改善C指数(C指数差值: 0.007; P=0.143)。

临床怎么用

  • GPSCAD可能用于无严重收缩功能障碍的冠心病患者的SAD风险分层,识别可能从除颤器治疗中获益的人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A familial predisposition to sudden and/or arrhythmic death (SAD) in the setting of coronary artery disease (CAD) exists; however, the genetic basis is poorly understood. OBJECTIVES: The purpose of this study was to determine whether a genome-wide polygenic score for coronary artery disease (GPSCAD) might have utility in SAD risk stratification in CAD patients without severe systolic dysfunction. METHODS: A previously validated GPSCAD was generated utilizing genome-wide genotyping in 4,698 PRE-DETERMINE participants of European ancestry with CAD and left ventricular ejection fraction >30%-35%. The population was dichotomized according to top GPSCAD decile as defined by the general population, and absolute, proportional, and relative risks for SAD and non-SAD were estimated using competing risk analyses. RESULTS: Over a median follow-up of 8.0 years, participants in the top GPSCAD decile were at elevated absolute SAD risk (8.0%; 95% CI: 5.1%-12.4% vs 4.8%; 95% CI: 3.3%-7.0%; P = 0.005) and proportional SAD risk (29% vs 16%; P = 0.0003) compared with the remainder. After controlling for left ventricular ejection fraction, clinical factors, and electrocardiogram parameters, the top GPSCAD decile was associated with SAD (subdistribution HR: 1.77; 95% CI: 1.23-2.54; P = 0.002) but not non-SAD (subdistribution HR: 1.00; 95% CI: 0.80-1.25; P = 0.98) (P for Δ = 0.003). The addition of the top GPSCAD decile to the multivariable model significantly improved net reclassification indexes (NRIs) (continuous NRI: 14.0%; P = 0.024; and categorical NRI: 6.6%; P = 0.005) but not the C-index (difference in C-index: 0.007; P = 0.143). CONCLUSIONS: Among CAD patients without severe systolic dysfunction, high GPSCAD specifically predicted SAD and enriched for both absolute and proportional SAD risk, identifying a population who might benefit from defibrillator therapy.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Sandhu RK, Dron JS, Liu Y, et al. Polygenic Risk Score Predicts Sudden Death in Patients With Coronary Disease and Preserved Systolic Function. J Am Coll Cardiol. 2022. PMID: 36007985. doi:10.1016/j.jacc.2022.05.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。